tirzepatide weight loss outcome
5 Lies About Semaglutide That Hurt Patients
Tirzepatide produces a 14.2% greater median weight loss than semaglutide in head-to-head trials, making it the more potent GLP-1-based therapy for obesity. This advantage emerges from its dual GLP-1 and GIP receptor agonism and has been confirmed across real-world studies and clinical guidelines. Medical Disclaimer: This article is for